Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels

医学 再狭窄 靶病变 西罗莫司 经皮冠状动脉介入治疗 冠状动脉 临床终点 支架 病变 心肌梗塞 心脏病学 外科 内科学 药物洗脱支架 动脉 放射科 临床试验
作者
Alessandro Sciahbasi,Nicolò Salvi,Tay Mok Heang,Ignacio Sánchez-Pérez,Salvatore Geraci,Giovanni Vaccaro,Susanna Benincasa,Amin Ariff Nuruddin,Raymundo Ocaranza,Francesco Giannini,Antonio Greco,Bernardo Cortese
出处
期刊:Catheterization and Cardiovascular Interventions [Wiley]
卷期号:103 (4): 532-538 被引量:1
标识
DOI:10.1002/ccd.30996
摘要

Abstract Background Studies evaluating the safety and efficacy of drug coating balloons (DCB) for the treatment of lesions in large coronary vessel are limited. Aims Our study aimed to evaluate the performance of a sirolimus DCB in large coronary arteries. Methods We analyzed all the procedures included in the EASTBOURNE Registry (NCT03085823) enrolling patients with a clinical indication to percutaneous coronary intervention performed by a sirolimus DCB according to investigator judgment. In the present analysis, a cut‐off of 2.75 mm was used to define large coronary arteries. Primary endpoint of the study was clinically driven target lesion revascularization (TLR) at 24 months whereas secondary endpoint included procedural success, myocardial infarction (MI), cardiac death and total mortality. Results Among the 2123 patients and 2440 lesions enrolled in the EASTBOURNE study between 2016 and 2020, 757 patients/810 lesions fulfilled the criteria for the present analysis. Mean reference vessel diameter was 3.2 ± 0.3 mm with mean lesion length of 22 ± 7 mm. Procedural success was high (96%) and at 2‐year follow up the device showed a good efficacy with a TLR rate of 9%. There were 34 deaths (4.5%), 30 MIs (4%) and 8 BARC type 3–5 bleedings (1.1%). In‐stent restenosis (629 lesions) and de novo lesions (181) were associated with 11% and 4% rates of TLR at 2 years, respectively ( p = 0.003). Conclusions Clinical performance of a sirolimus DCB in large coronary artery vessels shows promising signals at 2‐year follow up, both in de novo and in‐stent restenosis lesions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
祁问儿完成签到 ,获得积分10
刚刚
刚刚
FashionBoy应助浮生若梦采纳,获得10
刚刚
小禾一定行完成签到 ,获得积分10
1秒前
阿Q完成签到,获得积分10
3秒前
Leukocyte发布了新的文献求助10
4秒前
天天快乐应助小肥吴采纳,获得10
4秒前
6秒前
充电宝应助重要的菲鹰采纳,获得10
6秒前
科研宇发布了新的文献求助10
6秒前
Blaseaka完成签到 ,获得积分10
7秒前
qing123发布了新的文献求助30
7秒前
lara应助11采纳,获得10
8秒前
学疯发布了新的文献求助10
8秒前
华仔应助谢佳冀采纳,获得10
11秒前
念姬发布了新的文献求助10
12秒前
Guoguocheng完成签到,获得积分10
12秒前
12秒前
13秒前
chenxi完成签到,获得积分20
13秒前
13秒前
XLL小绿绿发布了新的文献求助10
14秒前
Nevaeh完成签到,获得积分10
14秒前
llls完成签到 ,获得积分10
14秒前
15秒前
大虫发布了新的文献求助10
16秒前
17秒前
研友-wbg-LjbQIL完成签到,获得积分10
17秒前
陈过年完成签到 ,获得积分10
19秒前
31313发布了新的文献求助10
19秒前
科研宇完成签到,获得积分10
19秒前
烟花应助学疯采纳,获得10
20秒前
21秒前
浮生若梦发布了新的文献求助10
22秒前
22秒前
旺仔发布了新的文献求助10
24秒前
开心苠完成签到 ,获得积分10
24秒前
lang发布了新的文献求助20
25秒前
小马甲应助科研通管家采纳,获得10
26秒前
8R60d8应助科研通管家采纳,获得10
26秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3962882
求助须知:如何正确求助?哪些是违规求助? 3508809
关于积分的说明 11143356
捐赠科研通 3241711
什么是DOI,文献DOI怎么找? 1791651
邀请新用户注册赠送积分活动 873058
科研通“疑难数据库(出版商)”最低求助积分说明 803579